Cvergenx Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Cvergenx General Information

Description

Provider of personalized radiation therapies intended to assist in radiation treatment planning. The company's personalized radiation therapies are integrated with a testing platform that applies genomic analysis to predict a tumor's response to radiation and to assist oncologists in determining the optimal level of radiation dosing, enabling oncologists to identify specific differences in tumor radiosensitivity to offer an accurate approach to patient care.

Contact Information

Website
www.cvergenx.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 990 31st Avenue North East
  • Saint Petersburg, FL 33704
  • United States
+1 (813)
Primary Industry
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 990 31st Avenue North East
  • Saint Petersburg, FL 33704
  • United States
+1 (813)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cvergenx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator Completed Generating Revenue
3. Angel (individual) 20-Jul-2017 Cancelled Generating Revenue
2. Angel (individual) 15-Dec-2015 $390K $613K Completed Generating Revenue
1. Angel (individual) 15-Apr-2010 $223K $223K Completed Startup
To view Cvergenx’s complete valuation and funding history, request access »

Cvergenx Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Cvergenx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3867411-A1 Systems and methods for personalized radiation therapy Pending 19-Oct-2018
US-11547871-B2 Systems and methods for personalized radiation therapy Active 19-Oct-2018
US-20200121948-A1 Systems and methods for personalized radiation therapy Active 19-Oct-2018
EP-3867411-A4 Systems and methods for personalized radiation therapy Pending 19-Oct-2018
US-20240131358-A1 Systems and methods for personalized radiation therapy Pending 19-Oct-2018 A61N5/1031
To view Cvergenx’s complete patent history, request access »

Cvergenx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cvergenx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tampa Bay Technology Incubator Accelerator/Incubator
To view Cvergenx’s complete investors history, request access »

Ready to get started?

Request a free trial

Cvergenx FAQs

  • When was Cvergenx founded?

    Cvergenx was founded in 2009.

  • Where is Cvergenx headquartered?

    Cvergenx is headquartered in Saint Petersburg, FL.

  • What is the size of Cvergenx?

    Cvergenx has 3 total employees.

  • What industry is Cvergenx in?

    Cvergenx’s primary industry is Biotechnology.

  • Is Cvergenx a private or public company?

    Cvergenx is a Private company.

  • What is Cvergenx’s current revenue?

    The current revenue for Cvergenx is .

  • How much funding has Cvergenx raised over time?

    Cvergenx has raised $613K.

  • Who are Cvergenx’s investors?

    Tampa Bay Technology Incubator has invested in Cvergenx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »